New research from a University of Cincinnati Cancer Center study found external beam radiation therapy (EBRT) is safe to ...
Stage 1 mixed cellularity Hodgkin lymphoma is often highly treatable, and many patients achieve long-term remission after frontline therapy. Advances in chemotherapy, radiation techniques and targeted ...
Spencer Laird was diagnosed with colon cancer at 26. At 30, he was told it had returned and spread to his lungs, with one tumor the size of a golf ball.
The selective estrogen receptor degrader giredestrant plus palbociclib (Ibrance) did not significantly improve progression-free survival (PFS) in advanced hormone receptor-positive/HER2-negative ...
A prospective, multicenter phase 2 trial evaluated the safety of neoadjuvant radiation plus immunotherapy before radical cystectomy for bladder cancer.
Neoadjuvant chemoimmunotherapy may beat immunotherapy alone when it comes to pathologic response, but its impact on survival remains to be seen.
Immunotherapy given during and after chemoradiation did not improve survival for study participants with limited-stage, small-cell lung cancer (SCLC) according to the results of an international ...
Head and neck squamous cell carcinomas (HNSCC) are the seventh-most prevalent form of cancer and are associated with human ...
After experiencing troubling symptoms for almost a year, Michael Douglas received some devastating news – a cancer diagnosis ...
The treatment landscape for breast cancer is shifting rapidly, driven by the rise of antibody-drug conjugates (ADCs), a class of treatments that are designed to deliver potent che ...
Salivary glands are essential for everyday human functions —speaking, swallowing, tasting and protecting the mouth—yet they ...